233 related articles for article (PubMed ID: 9696840)
41. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
Borrow P; Tishon A; Oldstone MB
J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
[TBL] [Abstract][Full Text] [Related]
42. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
[TBL] [Abstract][Full Text] [Related]
43. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss.
Varga SM; Selin LK; Welsh RM
J Immunol; 2001 Feb; 166(3):1554-61. PubMed ID: 11160196
[TBL] [Abstract][Full Text] [Related]
44. The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2.
Peacock CD; Lin MY; Ortaldo JR; Welsh RM
J Virol; 2000 Aug; 74(15):7032-8. PubMed ID: 10888642
[TBL] [Abstract][Full Text] [Related]
45. Gammaherpesvirus latency differentially impacts the generation of primary versus secondary memory CD8+ T cells during subsequent infection.
Barton ES; Rajkarnikar S; Langston PK; Price MJ; Grayson JM
J Virol; 2014 Nov; 88(21):12740-51. PubMed ID: 25142586
[TBL] [Abstract][Full Text] [Related]
46. Mice deficient in stem cell antigen-1 (Sca1, Ly-6A/E) develop normal primary and memory CD4+ and CD8+ T-cell responses to virus infection.
Whitmire JK; Eam B; Whitton JL
Eur J Immunol; 2009 Jun; 39(6):1494-504. PubMed ID: 19384870
[TBL] [Abstract][Full Text] [Related]
47. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection.
Sourdive DJ; Murali-Krishna K; Altman JD; Zajac AJ; Whitmire JK; Pannetier C; Kourilsky P; Evavold B; Sette A; Ahmed R
J Exp Med; 1998 Jul; 188(1):71-82. PubMed ID: 9653085
[TBL] [Abstract][Full Text] [Related]
48. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.
Selin LK; Welsh RM
J Immunol; 1997 Jun; 158(11):5366-73. PubMed ID: 9164957
[TBL] [Abstract][Full Text] [Related]
49. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
[TBL] [Abstract][Full Text] [Related]
50. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses.
Ostrowski MA; Justement SJ; Ehler L; Mizell SB; Lui S; Mican J; Walker BD; Thomas EK; Seder R; Fauci AS
J Immunol; 2000 Dec; 165(11):6133-41. PubMed ID: 11086046
[TBL] [Abstract][Full Text] [Related]
51. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
52. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
[TBL] [Abstract][Full Text] [Related]
53. Predicting the dynamics of antiviral cytotoxic T-cell memory in response to different stimuli: cell population structure and protective function.
Bocharov G; Klenerman P; Ehl S
Immunol Cell Biol; 2001 Feb; 79(1):74-86. PubMed ID: 11168627
[TBL] [Abstract][Full Text] [Related]
54. PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.
Tinoco R; Neubert EN; Stairiker CJ; Henriquez ML; Bradley LM
Front Immunol; 2021; 12():677824. PubMed ID: 34326837
[TBL] [Abstract][Full Text] [Related]
55. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
56. CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.
Sokke Umeshappa C; Hebbandi Nanjundappa R; Xie Y; Freywald A; Deng Y; Ma H; Xiang J
PLoS One; 2012; 7(10):e47004. PubMed ID: 23071696
[TBL] [Abstract][Full Text] [Related]
57. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.
Zarozinski CC; Welsh RM
J Exp Med; 1997 May; 185(9):1629-39. PubMed ID: 9151900
[TBL] [Abstract][Full Text] [Related]
58. A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.
Xie Y; Wang L; Freywald A; Qureshi M; Chen Y; Xiang J
Cell Mol Immunol; 2013 Jan; 10(1):72-7. PubMed ID: 23042534
[TBL] [Abstract][Full Text] [Related]
59. Residual LCMV antigen in transiently CD4
Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
[TBL] [Abstract][Full Text] [Related]
60. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
Moskophidis D; Zinkernagel RM
J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
